# Treatment of Breakthrough Cancer Pain According to European Guidelines

> **NCT04468490** · — · TERMINATED · sponsor: **Aziende Chimiche Riunite Angelini Francesco S.p.A** · enrollment: 131 (actual)

## Conditions studied

- Breakthrough Cancer Pain

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04468490
- **Lead sponsor:** Aziende Chimiche Riunite Angelini Francesco S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-08-11
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 131 (ACTUAL)
- **Why stopped:** Low enrollment rate
- **Last updated:** 2021-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04468490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04468490, "Treatment of Breakthrough Cancer Pain According to European Guidelines". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04468490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*